Why court ruling clears path for Cole Hutson to return to Texas football Austin American-Statesman

GE Aerospace GE and Northrop Grumman Corporation NOC are two familiar names operating in the aerospace and defense industry. As rivals, both companies are engaged in producing highly engineered aircraft components for commercial and military aircraft in the United States and internationally.Both companies have been enjoying significant growth opportunities in the aerospace and defense space on account of the improving air traffic trend and the expansionary U.S. budgetary policy over the past couple of years. Let’s take a closer look at their fundamentals, growth prospects and challenges.The Case for GE AerospaceGE Aerospace is benefiting from the higher utilization of engine platforms, driven by strong momentum and growth across commercial and defense aerospace sectors. Solid demand for LEAP, GEnx & GE9X engines and services, supported by growth in air traffic, fleet renewal and expansion activities, is driving the performance of the Commercial Engines & Services business.In the first half of 2026, the company secured several major engine orders and service agreements. GE clinched orders from United Airlines and Delta Air Lines to deliver GEnx engines, while it received orders for LEAP engines from American Airlines and Copa Airlines. Copa Airlines selected up to 120 LEAP-1B engines to power its expanding Boeing 737 MAX fleet. It also entered into a long-term materials agreement to support Ryanair’s fleet of about 2,000 CFM56 and LEAP engines.The company is also making progress under its FLIGHT DECK lean model, including supplier improvements that contributed to Commercial Engines & Services business’ revenues. In the second quarter of 2026, the segment’s engine deliveries increased 26% from the prior-year quarter, indicating better throughput as the company works through customer demand. The Commercial Engines & Services segment’s revenues and orders jumped 27% and 18%, respectively, on a year-over-year basis in the second quarter.Solid demand for the company’s propulsion & additive technologies, critical aircraft systems and aftermarket services in the defense sector is boosting the Defense & Propulsion Technologies business’ performance. GE received a contract from Turkish Aerospace Industries (“TAI”) to continue integrating its F404 engine into Türkiye's Hurjet jet trainer. It also clinched a $1.4 billion deal for T408 engines to support the U.S. Marine Corps’ CH-53K helicopter fleet. In second-quarter 2026, the Defense & Propulsion Technologies segment’s revenues increased 16% year over year and orders grew 12%.The company’s shareholder-friendly policies also add to its appeal. In the first six months of 2026, it paid dividends of $873 million, up 26.9% year over year, to its shareholders. It also raised its dividend by 30.6% to 36 cents per share in February 2026. In the same period, the company repurchased shares for $4.2 billion.The Case for Northrop GrummanNorthrop is expected to continue generating steady organic growth in 2026 and beyond as it continues to win new awards and thereby convert the robust backlog, which was $104.7 billion as of June 30, 2026, into solid sales growth. Such a robust backlog count is backed by increasing demand for the company’s defense products and rising global defense budget support, which in turn should boost Northrop’s revenue-generating prospects substantially.The current U.S. government’s inclination toward strengthening the nation’s defense system should act as a growth catalyst for defense contractors like Northrop. Considering that sales from Northrop to the U.S. government comprised 84% of its total sales in 2025, solid funding provisions from the administration are expected to lead to a solid inflow of contracts for Northrop. Foreign military sales also serve as a key growth catalyst for Northrop. The company’s international sales totaled $1.54 billion in the second quarter of 2026, comprising 14% of total sales. Region-wise, Northrop is witnessing significant opportunities for its Integrated Battle Command System (IBCS) and other weapons in Europe. Moreover, the long-standing conflicts in different parts of the Middle East have also been fueling demand for modern defense products.NOC also remains committed to rewarding its shareholders through dividends and buybacks. In the first six months of 2026, it paid dividends of $684 million, up 7.9% year over year, to its shareholders. It also raised its dividend by 6.9% to $2.47 per share in May 2026. In the same period, the company repurchased shares for $68 million.Despite the positives, NOC’s highly leveraged balance sheet remains concerning. Exiting the second quarter, Northrop’s long-term debt was high at $14.4 billion. Considering the high debt level, its cash and cash equivalents of $2.3 billion do not look impressive.Price PerformanceImage Source: Zacks Investment ResearchIn the past six months, GE Aerospace shares have risen 15%, while Northrop stock has lost 21.9%.The Zacks Consensus Estimate for GE & NOCImage Source: Zacks Investment ResearchThe Zacks Consensus Estimate for GE’s 2026 sales and earnings per share (EPS) implies year-over-year growth of 19.7% and 23.4%, respectively. EPS estimates for both 2026 and 2027 have increased over the past 60 days.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for Northrop’s 2026 sales and EPS implies year-over-year growth of 4.9% and 9.5%, respectively. EPS estimates for both 2026 and 2027 have been raised over the past 60 days.Valuation of GE & NorthropImage Source: Zacks Investment ResearchNorthrop is trading at a forward 12-month price-to-earnings ratio of 17.99X, close to its median of 18.74X over the last three years. GE’s forward earnings multiple sits at 41.88X, higher than its median of 37.01X over the same time frame.Final TakeGE Aerospace’s strong momentum in the commercial and defense aerospace markets, driven by solid build rates, wide-body aircraft demand and a robust defense budget, bodes well for growth. Given the strength across most of its served markets, GE has built a sound liquidity position that supports its shareholder-friendly policies.In contrast, Northrop’s strength in the defense aerospace market, along with its robust pipeline of projects, favors well for its growth. Its shareholder-friendly policies add to its appeal. However, this has been marred by the supply-chain challenges and high debt level, which might affect its performance.Despite its steeper valuation, GE holds robust prospects due to strong estimates, stock price appreciation and better prospects for sales and profit growth. Given these factors, GE seems a better pick for investors than Northrop currently. While GE carries a Zacks Rank #2 (Buy), Northrop currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Constellium SE CSTM and Ryerson Holding Corporation RYZ are leading players in the aluminum industry, supported by global operations and diversified business portfolios. With aluminum prices remaining elevated amid global economic uncertainty and persistent trade tensions, comparing these companies can help investors identify opportunities within the Zacks Metal Products - Distribution industry.Aluminum has become an attractive investment due to growing demand from electric vehicles, increased use of recycled aluminum and advancements in rechargeable batteries. Its demand is also rising as industries focus more on sustainability and efficiency. In addition, the recovery in global air travel has led aircraft manufacturers to increase production, driving higher demand for aluminum used in aircraft parts such as fuselages and wings.But which of these two stocks is better positioned to capitalize on these trends? Let’s compare their fundamentals to find out.The Case for ConstelliumConstellium’s Packaging & Automotive Rolled Products segment remains a key growth driver. In the second quarter of 2026, the segment’s revenues increased 36% year over year to $1.7 billion, driven by higher metal prices. It also benefited from supply shortages of automotive rolled products in North America, which supported the overall performance.Also, strength in the Aerospace & Transportation segment is aiding CSTM. The segment’s shipments increased 21% to 65 thousand metric tons in the second quarter of 2026, driven by higher shipments of aerospace and transportation, industry and defense (TID) rolled products. Revenues from the segment increased 38% to $680 million, supported by strong shipments and higher metal prices.The company’s Automotive Structures & Industry segment’s revenues grew 9% year over year to $458 million in the second quarter of 2026, supported by higher metal prices. Stable shipments compared with the prior-year quarter also supported the segment’s performance.CSTM also remains committed to rewarding its shareholders handsomely through share buybacks. For instance, it generated a solid free cash flow of $95 million in the first six months of 2026 and returned approximately $48 million to shareholders through share repurchases. It’s worth noting that in March 2026, the company’s board authorized a new share repurchase program of up to $300 million. The program became effective on May 21, 2026, and will remain in effect till Dec. 31, 2028.However, Constellium has been witnessing the impacts of escalating costs and expenses over time. In the second quarter of 2026, the cost of sales increased 23.3% year over year. Selling and administrative expenses also rose 14.8% in the quarter. The increase in operating expenses, if not controlled, might adversely impact the company’s margins in the quarters ahead.The Case for RyersonRyerson benefits from a diversified business structure that helps offset weakness in one end market with strength in others. The company is well-positioned to benefit from rising infrastructure spending, reshoring trends, increased fabrication outsourcing and ongoing manufacturing supply-chain restructuring. Also, its investments in expanding its non-ferrous polishing, buffing and grinding capabilities are expected to bolster the company's long-term position in the market.A key growth driver for Ryerson remains its aluminum product line. Aluminum prices and Midwest premiums increased during the second quarter of 2026, primarily due to supply disruptions in the Middle East. RYZ’s Aluminum shipments increased 10% year over year to 55,000 tons during the quarter. Revenues from the product line surged 41.8% to $434 million, aided by higher metal prices.In the same period, shipments from both the carbon steel and stainless steel product lines increased 67% and 45%, year over year, respectively. Also, revenues from these product lines grew 89.3% and 63.8%, respectively, due to an increase in average selling prices.In the second quarter, Ryerson’s total revenues increased 71.6% year over year to $2 billion, while total shipments rose 60.5% to 804,000 tons. For the third quarter of 2026, the company expects net sales of $1.87-$1.95 billion. Average selling prices are expected to remain flat or increase up to 2%.However, the company’s warehousing, delivery, selling, general and administrative expenses increased 58.7% year over year to $320.3 million in the second quarter. The increase mainly reflected the addition of Olympic Steel’s operating expenses and higher costs associated with the expanded revenue and shipment base.Also, high debt levels remain a concern for Ryerson. It exited the second quarter of 2026 with total debt of $955 million and net debt of $913 million, up $47 million and $30 million, respectively, from the first quarter of 2026. The increase reflected higher working capital requirements associated with increased revenues.How Does the Zacks Consensus Estimate Compare for CSTM & RYZ?The Zacks Consensus Estimate for CSTM’s 2026 sales and earnings per share (EPS) implies year-over-year growth of 30.6% and 84.9%, respectively. The company’s EPS estimates for 2026 have increased 6.3% over the past 30 days.Image Source: Zacks Investment ResearchWhile the consensus estimate for RYZ’s 2026 sales implies year-over-year growth of 53.9%, the same for EPS indicates an increase of 170.5%. The company’s EPS estimates remained steady over the past 30 days for 2026.Image Source: Zacks Investment ResearchPrice Performance and Valuation of CSTM & RYZIn the past six months, Constellium’s shares have surged 20.5%, while Ryerson stock has declined 8.6%.Image Source: Zacks Investment ResearchConstellium is trading at a forward 12-month price-to-earnings ratio of 9.42X compared with its median of 9.99X over the last five years. Ryerson is trading at a forward 12-month price-to-earnings ratio of 15.68X, above its median of 10.44X over the last five years.Image Source: Zacks Investment ResearchFinal TakeConstellium continues to witness strength across its key business segments, supported by favorable aluminum pricing. Also, its commitment to returning capital to shareholders augurs well for its long-term growth prospects. However, rising operating costs remain a concern for its margins.In contrast, Ryerson is benefiting from its diversified business model, robust momentum in its aluminum product portfolio and improving demand across steel categories, supported by higher metal prices. The company is well-positioned for continued growth, driven by healthy shipment volumes. However, increasing expenses and elevated debt levels continue to pose risks to its financial performance.Given these factors, CSTM seems a better pick for investors than RYZ currently. While Constellium carries a Zacks Rank #3 (Hold), RYZ currently has a Zacks Rank #5 (Strong Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

A Los Angeles Police Department officer was charged with 16 felonies Friday for illegally recording conversations with his fellow officers that allegedly contained sexist, homophobic and racist remarks, the Los Angeles County District Attorney’s Office announced. The officer, 43-year-old Daniel Flores, allegedly taped portions of conversations while he was assigned to a unit that performed [...]

Elon Musk’s Fortune Slumps to Pre-SpaceX IPO Levels After Rout Bloomberg Law News

New fossil discoveries from China are being hailed as evidence that could reshape our understanding of the origin of complex animal life. Does the new find solve the mystery of the Cambrian explosion? Are the headlines about these fossils justified? Are these in fact the long-lost ancestors of the Cambrian animals we’ve been looking for? On this ID The Future, host Andrew McDiarmid welcomes Dr. Casey Luskin to the show to to examine the evidence, ambiguity, and ongoing controversy surrounding newly reported Ediacaran bilaterian fossils. Source

Friends and loved ones gathered Thursday night and Friday morning to remember a teenager killed in a crash involving an electric motorcycle and a Tesla in Burbank earlier this week. A small memorial was seen set up near the intersection of Hollywood Way and Alameda Avenue, where flowers, candles, stuffed animals and handwritten messages honor [...]

The Zacks Glass Products industry is poised to benefit from the rising demand for glass, both as a packaging option and for use in construction. This is backed by its endless recyclability and sustainability benefits. Growing demand for energy-efficient, smart windows or smart glass panels will be another catalyst for the industry going forward.Companies like O-I Glass, Inc. OI and Apogee Enterprises APOG are expected to gain from efforts to capitalize on this demand by boosting capacity and introducing innovative products to the market.About the IndustryThe Zacks Glass Products industry comprises companies that manufacture and sell glass products. O produces glass containers for packaging beverages, food and pharmaceuticals. Another player in the industry offers coated and high-performance glass used in customized window and wall systems. It caters to the construction industry, ranging from commercial and multi-family residential to institutional buildings. It also provides coated glass for picture framing, wall décor and display applications. Nowadays, companies that make glass for buildings offer smart glass windows using artificial intelligence to adjust and suitably increase access to natural light while minimizing heat and glare. Some have developed electrokinetic technology that can be retrofitted on any glass, enabling buildings to cut energy consumption and save on heating and cooling costs.Major Trends Shaping the Future of the Glass Products IndustryGlass Packaging Gaining Popularity: Glass is increasingly becoming the packaging choice for customers, given its endless recyclability without a loss in quality. More than 80% of recycled bottles are used in making new bottles. This also helps negate the need for raw materials. Every ton of recycled glass saves 1,400 pounds of sand, 430 pounds of soda ash and 400 pounds of limestone/dolomite. As consumers are becoming more aware of their environmental footprint, a sharp spike in demand is noticed for refillable bottles, which offer the most sustainable and economical rigid packaging option. Manufacturers are focusing on improving their products by reducing the weight of the bottles for more convenient handling. Also, premium cosmetic and beverage brands are opting for glass to differentiate their products through packaging and ensure quality maintenance. Demand in the Construction Sector Holds Promise: In recent years, the use of glass gained popularity in construction as a sustainable alternative to traditional building materials, including wood and bricks, owing to its cost-effectiveness, lightweight, immense strength and environmentally friendly factor. Glass increases the influx of natural light in the building, reduces energy consumption, minimizes carbon emissions and enhances the aesthetic appeal of structures. Rising construction activities across the residential, commercial and industrial sectors are likely to fuel the glass products industry’s growth. Increasing investments in the renovation or modernization of the existing infrastructure will also drive the industry’s growth. Various governments are introducing favorable policies and granting incentives to promote green construction to minimize greenhouse emissions and energy consumption, which bodes well for the industry.Technological Innovation is the Key: Some players revolutionized the industry by bringing smart glass panels or smart windows to the market. These innovative products are designed to enable people to lead healthier and more productive lives by increasing access to daylight and views while minimizing glare and heat from the sun and keeping occupants comfortable. These products also help cut down on energy consumption from lighting and HVAC, thus reducing carbon emissions.Pricing, Improving Efficiency to Offset Cost Inflation: The industry is witnessing rising costs for transportation, chemical and fuel, and supply-chain headwinds. Therefore, industry players are increasingly focusing on pricing actions and cost reduction and resorting to automation in manufacturing to boost productivity and efficiency.Zacks Industry Rank Indicates Bright ProspectsThe Zacks Glass Products industry is a two-stock group within the broader Industrial Products sector. The industry currently carries a Zacks Industry Rank #11, which places it in the top 4% of the 246 Zacks industries.The group’s Zacks Industry Rank, basically the average of the Zacks Rank of all the member stocks, indicates bullish prospects in the near term. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.Before we present two Glass Products stocks for investors’ consideration, it is worth looking at the industry’s stock-market performance and its valuation picture.Industry Versus S&P 500 & SectorThe Glass Products industry has underperformed the S&P 500 and the sector in the past year. The stocks in this industry have collectively declined 30.6% against the Industrial Products sector’s gain of 17.5%. The S&P 500 composite has risen 21.7% during the said time frame.One-Year Price Performance Industry's Current ValuationBased on the trailing 12-month EV/EBITDA ratio, a commonly used multiple for valuing Glass Products companies, we see that the industry is currently trading at 4.37X compared with the S&P 500’s 18.32X and the Industrial Products sector’s 20.01X. This is shown in the charts below.Enterprise Value/EBITDA (EV/EBITDA) Ratio (TTM)Enterprise Value/EBITDA (EV/EBITDA) Ratio (TTM)Over the last five years, the industry traded as high as 9.42X and as low as 3.53X, the median being 5.20X.2 Glass Products Stocks to WatchApogee: The company has been benefiting from the strong performance of its Architectural Services segment, which is gaining on improved pricing and product mix, reflecting its strategic shift toward more premium products. The company’s strong project pipeline and recent order trends bode well. Apogee's ongoing efforts to reduce costs and enhance productivity are expected to bolster margins in the coming quarters. Its solid balance sheet provides additional support. Earlier this month, Apogee acquired Kalwall Companies. This deal is expected to solidify APOG’s Architectural Glass segment. Apogee expects this deal to yield $4 million of operational cost synergies by the end of fiscal 2029. Moreover, Kalwall is expected to generate $85 million in revenues within the first 12 months of the deal completion. The company expects an adjusted EBITDA margin of 15%, with a long-term margin target of 20%. The deal is also expected to be accretive to the company’s adjusted earnings in the first year of completion. APOG shares have gained 9.8% in the past three months. The Minneapolis, MN-based entity has a trailing four-quarter earnings surprise of 12.2%, on average. The Zacks Consensus Estimate for earnings for fiscal 2027 has moved up 3% to $2.96 per share over the past 60 days. The company has a long-term earnings growth of 12%. Apogee currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Price & Consensus: APOGO-I Glass: The company continues to invest in joint ventures, incremental capacity, and acquisitions to benefit from the growing demand for glass packaging due to increasing consumer preference for healthy, premium and sustainable products for food and beverage. O-I Glass is currently implementing the first phase of its Fit to Win initiative. This program is expected to reduce redundant production capacity, optimize the network and streamline costs in areas such as selling, general and administrative expenses. The program delivered $300 million of benefits in 2025, higher than the expected $250 million. Year to date, gross savings totaled $115 million or $85 million net savings. OI expects approximately $200 million of Fit to Win benefits in 2026 and at least $650 million over 2024-2027. This is expected to drive higher earnings, enhance economic profit and strengthen free cash flow. Perrysburg, OH-based O-I Glass manufactures and sells glass containers to food and beverage manufacturers, primarily in the Americas, Europe and the Asia Pacific. OI has a long-term estimated earnings growth rate of 7.3%. O-I Glass currently carries a Zacks Rank #3 (Hold). Price & Consensus: OI Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

‘Did he just flirt with me?’ Aussie mum’s Facebook Marketplace sale turned into true love thatslife.com.au

Layne Named Longwood Softball Graduate Assistant Coach Longwood University Athletics

Missouri voters are deciding on a measure that could make it much harder to amend the state constitution. Proposed Amendment 4 on Tuesday's ballot would require future amendments proposed by citizen initiatives to pass in all eight congressional districts, not just by a simple statewide majority. No other state has such a high standard. Supporters say it ensures all voices are heard. But critics argue it undermines majority rule. The proposal applies only to citizen initiatives, not those referred by the Legislature. Missouri's measure comes after other states have tried to make it harder to pass initiated amendments by requiring a 60% threshold statewide.

Cracker Barrel Old Country Store (CBRL) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The upward trend in estimate revisions for this restaurant operator reflects growing optimism of analysts on its earnings prospects, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.Consensus earnings estimates for the next quarter and full year have moved considerably higher for Cracker Barrel Old Country Store, as there has been strong agreement among the covering analysts in raising estimates.The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:12 Month EPSCurrent-Quarter Estimate RevisionsThe company is expected to earn $0.12 per share for the current quarter, which represents a year-over-year change of -83.8%.Over the last 30 days, two estimates have moved higher for Cracker Barrel compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 136.74%.Current-Year Estimate RevisionsThe company is expected to earn $0.01 per share for the full year, which represents a change of -99.7% from the prior-year number.In terms of estimate revisions, the trend for the current year also appears quite encouraging for Cracker Barrel. Over the past month, three estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 100.9%.Favorable Zacks RankThanks to promising estimate revisions, Cracker Barrel currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineWhile strong estimate revisions for Cracker Barrel have attracted decent investments and pushed the stock 6.7% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Core Laboratories Inc. CLB shares lost 47.1% in the past 6 months, in contrast to the Oil and Gas - Field Services industry’s rise of 3.9%. The shares of the company trades near a depressed level after a sharp selloff, but the investment case is not one-sided.Image Source: Zacks Investment ResearchThe stock offers a lower valuation, an asset-light model and improving technology adoption in Production Enhancement. Those positives must be weighed against falling earnings, geopolitical disruptions and limited near-term visibility.CLB Valuation Offers Upside With Execution RiskCLB’s share price of $10.35 compares with a 6-12 month price target of $13. The discount points to potential upside, but the longer-term view remains measured because operating recovery is still uneven.The stock trades at 0.79X forward 12-month sales, below its five-year median of 1.58X. Its trailing 12-month enterprise value-to-earnings before interest, taxes, depreciation and amortization multiple is 8.07X, also below the five-year median of 13.99X. Valuation is helpful, but stronger earnings execution is needed to make the discount more convincing.Image Source: Zacks Investment ResearchCore Laboratories Earnings Trends Stay UnevenCore Lab reported second-quarter 2026 adjusted earnings of 11 cents per share, above expectations of 8 cents. The result still declined from 19 cents in the year-ago quarter.Revenues fell 4.3% year over year to $124.6 million. Six-month operating income declined 44% to $11 million, while the current-year earnings estimate moved 4.5% lower over the past four weeks. SLB SLB, a larger oilfield technology peer, provides a relevant comparison for investors tracking offshore and international spending cycles. Halliburton Company HAL is another key services peer because its completions exposure overlaps with activity trends that influence CLB’s Production Enhancement business.CLB Cash Flow Supports Capital ReturnsCore Lab’s asset-light model remains central to the bull case. Low capital spending requirements and service-oriented operations help the company preserve cash during uneven industry conditions.Second-quarter free cash flow was $3.1 million. CLB also paid its quarterly dividend and repurchased 214,712 shares for $2.7 million, marking the seventh consecutive quarter of buybacks. Net debt decreased by $0.5 million during the quarter, but modest cash generation limits how quickly the company can reduce debt while funding dividends, repurchases and growth investments.Core Laboratories Catalysts Depend on RecoveryPotential catalysts remain tied to international exploration, offshore activity and wider use of proprietary technologies. Production Enhancement revenues rose 15% sequentially and 5% year over year, with operating margins reaching 12%.Core Lab secured work tied to projects in Australia, Namibia and Côte d’Ivoire. It also received regulatory approval to deploy SpectraStim and SpectraScan technologies in the United Arab Emirates. Still, Reservoir Description revenues fell 9% year over year, with margins of 5%, as Middle East activity, crude assay work and Russia-Ukraine-related sanctions pressured demand.CLB Scores Favor Value Over GrowthThe bottom line is that CLB looks cheaper after the selloff, but the stock still requires patience. A valuation reset alone does not remove earnings volatility or geopolitical exposure.The stock currently carries a Zacks Rank #4 (Sell). That rank tempers the appeal of a Value Score of B because weaker estimate revisions remain a concern.You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.CLB also has a Growth Score of D, Momentum Score of C and VGM Score of D. The Style Scores suggest value characteristics are more favorable than growth and broader blended factors, but a weak Zacks Rank keeps the near-term setup cautious until revisions and operating momentum improve. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Dave Inc. DAVE and Upstart Holdings, Inc. UPST share the same core idea, which is that artificial intelligence can make consumer credit decisions faster, broader and more accurate than traditional methods. Both companies use proprietary models to judge risk, connect borrowers with financing and improve the customer experience through digital tools. They also depend on reliable funding partners and careful credit management to turn loan growth into durable profits.However, Dave focuses on everyday banking customers who need short-term liquidity, then aims to deepen those relationships through checking, debit and installment products. Upstart runs a larger lending marketplace spanning personal loans, auto loans, home equity products and revolving credit. Dave currently offers stronger margins and a tighter operating model, while Upstart brings more scale and product diversity. For investors, the better choice depends on execution, operating leverage, capital efficiency and the price investors are being asked to pay.The Case for DAVEDave’s appeal starts with a focused customer journey. ExtraCash addresses an immediate need between paychecks, giving the company a way to attract members. Dave can then offer those users a checking account, debit card and eventually Dave Flex. Upstart serves more lending categories, but Dave’s narrower approach makes cross-selling easier to understand and measure.CashAI is central to this model. Dave uses real-time transaction data rather than relying on traditional credit scores. The system has supported larger ExtraCash volumes while keeping losses controlled. In the first quarter, originations rose 37%, yet the 28-day past-due rate improved to 1.69%. That evidence matters because growth in short-term credit is only useful when repayment performance remains sound.Dave also converts growth into profit more effectively than Upstart. Its adjusted EBITDA margin reached 44% compared with 13% for Upstart. Member growth and higher revenue per user supported that result, but the broader point is operating leverage: Dave’s digital platform can serve more activity without expenses rising at the same pace.The Coastal Community Bank funding arrangement could improve the model further. Moving ExtraCash receivables toward an off-balance-sheet structure should release liquidity and reduce Dave’s direct funding burden. It also gives management more room to invest in customer acquisition, new products or share repurchases.Dave still faces regulatory, partner and product-launch risks. Flex must prove that it can add spending without weakening credit quality. Even so, Dave combines a clear strategy, strong margins, improving underwriting results and a credible path toward a more capital-efficient business.The Case for UPSTUpstart’s strength is breadth. Its AI platform supports unsecured personal loans, auto loans, home equity lines and the Cash Line. This gives lending partners access to several credit categories through one technology provider. Compared with Dave, this broader reach creates greater upside, but it also requires Upstart to manage more products, partners, funding channels and credit cycles.The company also has scale. Upstart facilitated about $3.4 billion of originations in the first quarter, with personal loans providing the core volume. More than 90% of loans were fully automated, showing how its software can speed up borrower decisions.Funding conditions have improved. Multi-year forward-flow commitments, securitizations, and relationships with banks and credit unions give Upstart several capital sources. Conditional approval to establish a national bank could eventually simplify operations and expand product reach, although further regulatory approvals are still required.The concern is that stronger volume has not yet produced the same earnings quality seen at Dave. Upstart’s first-quarter adjusted EBITDA margin fell to 13%, contribution margin declined to 50%, and the company reported a GAAP net loss. Management expects margins to improve as spending moderates and newer products mature, but that outcome depends on execution and a stable credit environment.Upstart remains an interesting AI lending platform with strong technology, broad product exposure and improved funding visibility. However, its business is more complex and more sensitive to lender demand, capital markets and consumer credit conditions.How Do Estimates Compare for DAVE & UPST?The Zacks Consensus Estimate for Dave’s 2026 and 2027 sales implies year-over-year growth of 28.85% and 19.93%, respectively. The consensus mark for 2026 and 2027 EPS suggests a year-over-year increase of 27.47% and 28.63%, respectively. Over the past 30 days, estimates for DAVE’s 2026 and 2027 EPS have been revised upward. For Dave:Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for Upstart’s 2026 and 2027 sales calls for year-over-year growth of 36.53% and 30.61%, respectively. The consensus estimates for both 2026 and 2027 EPS have been revised marginally downward over the past 30 days. However, the figures suggest a year-over-year increase of 29.31% and 44.89%, respectively. For Upstart:Image Source: Zacks Investment ResearchPrice Performance and Valuation of DAVE & UPSTSo far in the year, Dave shares have surged 70%, while Upstart shares have declined 38.4%. In comparison, the S&P 500 composite has advanced 8.2% in the same time frame. Image Source: Zacks Investment ResearchFollowing the share rally, DAVE is trading at a forward 12-month price-to-sales of 6.03X, which is above its one-year median of 4.54X. Meanwhile, UPST is presently trading at a forward 12-month price-to-sales of 1.54X, which is below its one-year median of 3.08X. This indicates that investors already pay a large premium for Dave’s stronger margins, cleaner execution, and more focused model. Upstart’s lower ratio offers more room for upside if profitability improves, but it also reflects greater sensitivity to funding markets and credit conditions.Image Source: Zacks Investment ResearchConclusionBoth companies have credible AI-driven lending models, but Dave presents the cleaner investment case today. Its focused customer strategy, improving credit results, high adjusted EBITDA margin and Coastal funding transition provide a stronger mix of growth and operating control. Upstart has broader products, rising originations, committed funding and a bank charter, yet profitability remains less consistent, and the model depends more heavily on external credit conditions. Dave’s richer sales multiple raises the bar, so the stock is not low risk. Even so, it is the better name to add, while existing Upstart investors should stay patient rather than increase exposure.DAVE has a Zacks Rank #2 (Buy), while UPST carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

Astera Labs ALAB is set to report its second-quarter 2026 results on Aug. 4.For the second quarter of 2026, ALAB expects revenues between $355 million and $365 million, implying 15% to 18% sequential growth. Non-GAAP earnings are projected to be between 68 cents and 70 cents per share.The Zacks Consensus Estimate for second-quarter 2026 revenues is currently pegged at $360.24 million, indicating an increase of 87.70% from the figure reported in the year-ago quarter. The consensus mark for earnings is currently pegged at 69 cents per share, which has been unchanged over the past 30 days. This implies 56.82% year-over-year growth.Astera Labs, Inc. Price and EPS Surprise Astera Labs, Inc. price-eps-surprise | Astera Labs, Inc. QuoteALAB’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average earnings surprise of 21.42%. Let’s see how things have shaped up prior to this announcement.Factors to Note for ALAB’s Q2 EarningsAstera Labs’ second-quarter 2026 revenues are likely to have benefited from strong momentum across its three key product families, Aries, Taurus, and Scorpio. Continued adoption of PCIe 6 across AI platforms, rising Taurus volumes for AI scale-out connectivity and a sustained early-stage ramp-up of Scorpio X-Series products for large-scale XPU clustering are likely to have been key catalysts. A major contributor to second quarter growth is the ramp-up of the Scorpio product family, especially the Scorpio X-Series and P-Series AI fabric switches. The company began shipping initial production volumes of the Scorpio X-Series in the first quarter of 2026 and expects shipments to increase in the second quarter of 2026, including the new 320-lane Scorpio X model. These products are designed for large-scale XPU clustering applications and offer advanced features such as in-network compute and hypercast, which reduce networking overhead and improve performance for both training and inferencing workloads.ALAB’s signal conditioning portfolio, including Aries and Taurus products, is also expected to have driven the to-be-reported quarter’s performance. Aries revenue growth is fueled by strong adoption of PCIe 6 solutions across AI platforms, supporting both scale-up and scale-out connectivity. Taurus is anticipated to see increased volumes for AI scale-out connectivity, benefiting from broad adoption of Active Electrical Cables in both AI and general-purpose compute platforms. Together, these portfolios contributed more than one-third of total company revenues in the first quarter of 2026 and are projected to maintain momentum in the second quarter of 2026.However, ALAB’s second-quarter 2026 gross margin is expected to decline compared with the first quarter of 2026, with management guiding for approximately 73% non-GAAP gross margin compared with 76.4% in the first quarter of 2026. This decrease is primarily attributed to a 200 basis point non-cash impact from a recently executed warrant agreement with a customer. Ongoing supply chain challenges and increased operating expenses from strategic investments and acquisitions also remain a headwind.ALAB Shares Outperform Sector, IndustryAstera Labs shares have risen 80.2% in the year-to-date period, outperforming the broader Zacks Computer and Technology sector’s return of 6.9% and the Zacks Internet Software industry’s decline of 10.2%.ALAB Stock PerformanceImage Source: Zacks Investment ResearchAstera Labs stock is not so cheap, as the Value Score of F suggests a stretched valuation at this moment.In terms of the forward 12-month Price/Sales, ALAB is trading at 27.38X, higher than the Zacks Internet Software industry’s 3.79X.ALAB ValuationImage Source: Zacks Investment ResearchALAB Faces Stiff CompetitionDespite an expanding portfolio and strong partner base, ALAB is facing stiff competition from other industry players like Marvell Technology MRVL, Credo Technology CRDO and Cisco Systems CSCO. These companies are all expanding their footprints in the AI infrastructure space.Marvell Technology’s expanding portfolio has been noteworthy. In June 2026, Marvell Technology introduced the Teralynx T100, the industry’s first 102.4 Tbps AI-optimized switch silicon, delivering up to 25% lower power consumption and ultra-low latency to improve efficiency and scalability in large AI data center networks.Cisco Systems has been integrating AI into its product portfolios across networking, security, collaboration and observability. In the third quarter of fiscal 2026, AI infrastructure orders taken from hyperscalers totaled $1.9 billion in the reported quarter compared with $600 million in the year-ago quarter. Cisco Systems raised its fiscal 2026 hyperscaler AI infrastructure order outlook from $5 billion to $9 billion, and increased expected AI infrastructure revenues from $3 billion to $4 billion. Credo Technology’s expanding portfolio has been noteworthy. In May 2026, Credo Technology completed its acquisition of DustPhotonics, adding industry-leading silicon photonics technology to strengthen its optical interconnect portfolio across 800G, 1.6T and 3.2T solutions. The acquisition enhances Credo Technology’s vertically integrated AI connectivity stack and is expected to be a significant growth driver in fiscal 2027, supported by increasing hyperscale AI adoption.ConclusionAstera Labs’ strong fundamentals and rising AI demand reinforce its leadership in connectivity solutions. However, elevated R&D spending, acquisition-related investments and aggressive expansion efforts are pressuring profitability in the near term. Stiff competition and stretched valuation also remain concerns.Astera Labs currently has a Zacks Rank #3 (Hold), suggesting that it may be wise to wait for a more favorable entry point to accumulate the stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research

https://www.hollywoodreporter.com/tv/tv-news/netflix-walking-dead-streaming-deal-amc-global-media-1236659933/

Talarico leads Paxton, draws strong Black support in Texas poll Austin American-Statesman

Yves Saint Laurent was a man addicted to sex appeal. “Nothing is more beautiful than a naked body,” he said in the late 60s after debuting his first nearly nude designs, sheathing his female clients in translucent chiffon dresses and suggestive ostrich feathers. Bursting free from the confines of conservative French style, Saint Laurent was a pioneer for sexual freedom, reimaging dress not just as a pastime but a tool for liberation. On Augusthellip;read more raquo;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;View Gallery (10 images)nbsp;

Kenvue Inc. KVUE is slated to report second-quarter 2026 results on Aug. 6, before market open. The company is likely to report top and bottom-line increase when it posts the quarterly results.For revenues, the consensus mark is pegged at $4 billion, implying a rise of 3.9% from the year-ago quarter. The Zacks Consensus Estimate for the company’s earnings is pegged at 32 cents per share, which reflects an increase of 10.3% from the year-ago quarter’s figure. The consensus mark has been stable in the past 30 days. In the last reported quarter, the company delivered an earnings surprise of 18.5%. Its earnings beat the Zacks Consensus Estimate by 12.1%, on average, in the trailing four quarters.Key Factors to Influence KVUE’s Q2 ResultsKenvue’s quarterly performance is likely to have benefited from its iconic consumer health brands and strength in the Skin Health and Beauty division. The company is focused on strengthening its consumer health brands through product innovation, increased marketing investments and deeper consumer engagement. The Zacks Consensus Estimate for the Skin Health and Beauty segment is currently pegged at $1.1 billion, indicating a rise of 3% year over year.KVUE’s diversified portfolio reduces dependence on any single product or category. The Tylenol and Zyrtec consumption trends have been improving while Nicorette is gaining share across major international markets, and brand innovation supported broader consumer engagement. Continued investment in these franchises is likely to have boosted sustainable demand and market-share growth in the quarter under review.The company is prioritizing science-backed innovation and expanding products in categories to drive organic growth. Kenvue is simplifying its operating model, improving supply-chain efficiency and implementing productivity initiatives to reduce costs and support margins. The company is also working to improve execution across markets, optimize its portfolio and enhance digital and e-commerce capabilities. Such factors are likely to have aided the company’s performance during the quarter under review.On the flip side, the company has been witnessing weakness in its Self Care business for a while. The business remains exposed to unpredictable cold, flu and allergy seasons, which can create volatility in demand. Weak seasonal incidence across major markets has been hurting results, highlighting the segment’s dependence on external health patterns. Also, headwinds like tariffs, inflation, foreign exchange movements and supply-chain volatility remain deterrents.What the Zacks Model Unveils for KenvueOur proven model does not conclusively predict an earnings beat for Kenvue this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.Kenvue currently has an Earnings ESP of 0.00% and a Zacks Rank of 3.Kenvue Inc. Price and EPS Surprise Kenvue Inc. price-eps-surprise | Kenvue Inc. QuoteValuation Picture & Price PerformanceKenvue has a forward 12-month price-to-earnings ratio of 16.11X, lower than the Consumer Products - Staples industry’s average of 18.75X. The stock is trading above its median of 15.72X.The recent market movements show that KVUE’s shares have gained 10.8% in the past three months compared with the industry's 4.2% growth.Stocks With the Favorable CombinationHere are some companies, which according to our model, have the right combination of elements to beat on earnings this reporting cycle.Archer Daniels Midland Company ADM currently has an Earnings ESP of +11.52% and a Zacks Rank of 2. The consensus estimate for ADM’s quarterly revenues is pinned at $22.4 billion, which calls for 5.7% growth from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Archer Daniels’ upcoming quarter’s EPS is pegged at $1.27, which implies a 36.6% rise year over year. ADM delivered a trailing four-quarter earnings surprise of 5.4%, on average.Coty COTY has an Earnings ESP of +0.03% and a Zacks Rank of 3 at present. The company is expected to register a bottom and top-line decline when it reports fourth-quarter fiscal 2026 numbers. The Zacks Consensus Estimate for COTY’s quarterly bottom line has remained unchanged in the past 30 days at a loss of a cent per share. The consensus mark for earnings indicates an improvement of 80% from the figure reported in the year-ago quarter. The consensus estimate for quarterly revenues is pegged at $1.2 billion, which indicates a drop of 4.8% from the figure reported in the year-ago quarter. COTY has delivered a negative earnings surprise of 214.1%, on average, in the trailing four quarters.Monster Beverage Corporation MNST currently has an Earnings ESP of +2.61% and a Zacks Rank of 3. The company is likely to register bottom and top-line growth when it reports second-quarter 2026 numbers. The Zacks Consensus Estimate for Monster Beverage’s quarterly revenues is pegged at $2.4 billion, indicating an increase of 14.5% from the figure reported in the prior-year quarter. The consensus estimate for MNST’s quarterly earnings of 59 cents per share implies a rise of 13.5% from the year-ago quarter’s level. MNST has a trailing four-quarter earnings surprise of 9.6%, on average. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment Research